GTS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 49: | Line 49: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5. | ||
|- | |- | ||
|[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]] | |[[GTS5:Multiple_endocrine_neoplasia_type_2_(RET)|Multiple endocrine neoplasia type 2 (RET)]] | ||
| Line 71: | Line 71: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO DIG5. | ||
|- | |- | ||
|[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | |[[GTS5:Hereditary_neuroblastoma_(ALK,_PHOX2B)|Hereditary neuroblastoma (ALK, PHOX2B)]] | ||
| Line 82: | Line 82: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]] | |[[GTS5:Encephalocraniocutaneous_lipomatosis_(FGFR1)|Encephalocraniocutaneous lipomatosis (FGFR1)]] | ||
| Line 93: | Line 93: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]] | |[[GTS5:Glucagon_cell_hyperplasia_and_neoplasia_(GCGR)|Glucagon cell hyperplasia and neoplasia (GCGR)]] | ||
| Line 104: | Line 104: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5. | ||
|- | |- | ||
|[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]] | |[[GTS5:McCune-Albright_syndrome_(GNAS)|McCune-Albright syndrome (GNAS)]] | ||
| Line 115: | Line 115: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5, STBT5. | ||
|- | |- | ||
|[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]] | |[[GTS5:Sturge-Weber_syndrome_(GNAQ)|Sturge-Weber syndrome (GNAQ)]] | ||
| Line 126: | Line 126: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO EYE5. | ||
|- | |- | ||
|[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | |[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | ||
| Line 137: | Line 137: | ||
|Madina Sukhanova (Madina S) | |Madina Sukhanova (Madina S) | ||
| | | | ||
|Named based on GTS5 book. Also, content in online WHO EYE5, EYE5, HAN5, ENDO5, PEDS5, CNS5, SBTB5, BRST5. | |'''Named based on GTS5 book. Also, content in online WHO EYE5, EYE5, HAN5, ENDO5, PEDS5, CNS5, SBTB5, BRST5.''' | ||
|- | |- | ||
!'''Disease''' | !'''Disease''' | ||
| Line 170: | Line 170: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | |[[GTS5:Noonan_syndrome_(Various_genes)|Noonan syndrome (Various genes)]] | ||
| Line 181: | Line 181: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]] | |[[GTS5:Schimmelpenning-Feuerstein-Mims_(HRAS,_KRAS)|Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]] | ||
| Line 192: | Line 192: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]] | |[[GTS5:Carney_complex_(PRKAR1A,_PDE8B,_PDE11A)|Carney complex (PRKAR1A, PDE8B, PDE11A)]] | ||
| Line 203: | Line 203: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book Template added 7/12/24. Also, content in online WHO FEMA5, THOR5, MALE5, CNS5, ENDO5, SKIN5. | ||
|- | |- | ||
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]] | |[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]] | ||
| Line 214: | Line 214: | ||
| | | | ||
| | | | ||
| | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. No other books have content. | ||
|- | |- | ||
|[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | |[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | ||